National Bank of Canada’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
30,484
+20,854
| +217% | +$1.73M | ﹤0.01% | 884 |
|
|
2025
Q1 | $781K | Sell |
9,630
-3,292
| -25% | -$267K | ﹤0.01% | 1013 |
|
|
2024
Q4 | $1.16M | Sell |
12,922
-3,064
| -19% | -$276K | ﹤0.01% | 1014 |
|
|
2024
Q3 | $1.58M | Buy |
15,986
+1,589
| +11% | +$157K | ﹤0.01% | 894 |
|
|
2024
Q2 | $1.34M | Sell |
14,397
-196,239
| -93% | -$18.2M | ﹤0.01% | 891 |
|
|
2024
Q1 | $18.6M | Buy |
210,636
+202,259
| +2,414% | +$17.8M | 0.03% | 359 |
|
|
2023
Q4 | $755K | Sell |
8,377
-718
| -8% | -$64.7K | ﹤0.01% | 1059 |
|
|
2023
Q3 | $641K | Sell |
9,095
-1,974
| -18% | -$139K | ﹤0.01% | 1112 |
|
|
2023
Q2 | $920K | Buy |
11,069
+1,874
| +20% | +$156K | ﹤0.01% | 1043 |
|
|
2023
Q1 | $701K | Buy |
9,195
+3,530
| +62% | +$269K | ﹤0.01% | 1047 |
|
|
2022
Q4 | $304K | Buy |
5,665
+3,734
| +193% | +$200K | ﹤0.01% | 1241 |
|
|
2022
Q3 | $153K | Sell |
1,931
-3,539
| -65% | -$280K | ﹤0.01% | 1284 |
|
|
2022
Q2 | $411K | Sell |
5,470
-490,092
| -99% | -$36.8M | ﹤0.01% | 1075 |
|
|
2022
Q1 | $44.5M | Buy |
495,562
+455,057
| +1,123% | +$40.9M | 0.13% | 117 |
|
|
2021
Q4 | $4.53M | Buy |
+40,505
| New | +$4.53M | 0.02% | 500 |
|